Abstract
Purpose
This study aimed to assess the activity of A. austriaca flowers in treating polycystic ovary syndrome (PCOS) in rats.
Methods
A letrozole-induced PCOS rat model was used to evaluate the activity potential of A. austriaca flowers. For this purpose, extracts of different polarity were prepared from A. austriaca flowers using n-hexane, ethyl acetate, and methanol. Serum luteinizing hormone, follicle-stimulating hormone, progesterone, testosterone, estradiol, serum leptin, lipid, and glucose levels were tested. Moreover, the antioxidant activity was evaluated by calculating superoxide dismutase, malondialdehyde, catalase, and glutathione peroxidase levels. Following the biological activity studies, phytochemical studies were conducted on the active extract to detect the compound(s) responsible for the activity.
Results
The treatment with n-hexane extract contributed to regulating serum gonadotropin and steroid hormone levels. The plasma level of high-density lipoprotein cholesterol was significantly higher than that of the control group, while the levels of low-density lipoprotein cholesterol, leptin, and glucose were significantly lower than those of the control group. Also, the n-hexane extract showed significant antioxidant activity in the PCOS rat model. Since the n-hexane extract was found to be active, isolation studies were performed on this extract and three main fractions were obtained from the n-hexane extract. Those fractions also were tested on letrozole-induced PCOS rat model. As a result, three triterpenoids, β-amyrin palmitate, taraxasterol acetate, and taraxasterol were isolated and identified from Fr. B which is the most active fraction.
Conclusion
n-Hexane extract and Fr. B obtained from this extract showed statistically significant activity in the letrozole-induced PCOS rat model and three triterpene-type compounds were isolated from Fr. B.
Similar content being viewed by others
References
Grierson AJC, Yavin Z (1975) Anthemis L. In: Davis PH (ed) Flora of Turkey and the East Aegean Islands. University of Edinburgh Press, Edinburgh, pp 174–221
Fujita T, Sezik E, Tabata M, Yeşilada E, Honda G, Takeda Y (1995) Traditional medicine in Turkey VII. Folk medicine in Middle and West Black Sea regions. Econ Bot 49(4):406–422
Honda G, Yesilada E, Tabata M, Sezik E, Fujita T, Takeda Y, Takaishi Y, Tanaka T (1996) Traditional medicine in Turkey. VI. Folk medicine in West Anatolia: Afyon, Kütahya, Denizli, Muğla. Aydin provinces J Ethnopharmacol 53:75–87
Simsek I, Aytekin F, Yesilada E, Yıldırımlı Ş (2004) An ethnobotanical survey of the Beypazari, Ayas, and Güdül district towns of Ankara province (Turkey). Econ Bot 58(4):705–720
Kaval I, Behcet L, Cakilcioglu U (2014) Ethnobotanical study on medicinal plants in Gecitli and its surrounding (Hakkari-Turkey). J Ethnopharmacol 155(1):171–184
Tetik F, Civelek S, Cakilcioglu U (2013) Traditional uses of some medicinal plants in Malatya (Turkey). J Ethnopharmacol 146(1):331–346
Uysal I, Onar S, Karabacak E, Çelik S (2010) Ethnobotanical aspects of Kapıdağ Peninsula (Turkey). Biol Divers Conserv 3(3):15–22
Barbour EK, Al Sharif M, Sagherian VK, Habre AN, Talhouk RS, Talhouk SN (2004) Screening of selected indigenous plants of Lebanon for antimicrobial activity. J Ethnopharmacol 93(1):1–7
Shahat AA, Ibrahim AY, Elsaid MS (2014) Polyphenolic content and antioxidant activity of some wild Saudi Arabian Asteraceae plants. Asian Pac J Trop Med 7(7):545–551
Staneva J, Trendafilova-Savkova A, Todorova MN, Evstatieva L, Vitkova A (2004) Terpenoids from Anthemis austriaca Jacq. Z Naturforsch C 59(3–4):161–165
Kovanci E, Buster JE (2006) Polycystic ovary syndrome. In: Bieber EJ, Sanfilippo JS, Horowitz IR (eds) Clinical Gynecology. Churchill Livingstone, Philadelphia, PA, USA, pp 893–909
Kahn JA (2008) Polycystic ovary syndrome. In: Slap GB (ed) Adolesc Med. Mosby, Philadelphia, PA, USA, pp 165–174
Oyelowo T (2007) Polycystic ovary syndrome. In: Oyelowo T (ed) Mosby's Guide to Women's Health, Mosby, St. Louis, Missouri, USA, pp 176–179
Rezvanfar MA, Rezvanfar MA, Ahmadi A, Shojaei-Saadi HA, Baeeri M, Abdollahi M (2012) Molecular mechanisms of a novel selenium-based complementary medicine which confers protection against hyperandrogenism-induced polycystic ovary. Theriogenology 78(3):620–631
Rezvanfar MA, Ahmadi A, Saadi HS, Baeeri M, Abdollahi M (2012) Mechanistic links between oxidative/nitrosative stress and tumor necrosis factor alpha in letrozole-induced murine polycystic ovary: biochemical and pathological evidences for beneficial effect of pioglitazone. Hum Exp Toxicol 31(9):887–897
Aebi H (1984) Catalase in vitro. Methods Enzymol 105:121–126
Yagi K (1984) Assay for blood plasma or serum lipid peroxides methods. Methods Enzymol 105:328–331
Fisher CR, Graves KH, Parlow AF, Simpson ER (1998) Characterization of mice deficient in aromatase (ArKO) because of targeted disruption of the cyp19 gene. Proc Natl Acad Sci 95:6965–6970
Kafali H, Iriadam M, Ozardali I, Demir N (2004) Letrozole-induced polycystic ovaries in the rat: a new model for cystic ovarian disease. Arch Med Res 35:103–108
Reddy PS, Begum N, Mutha S, Bakshi V (2016) Beneficial effect of curcumin in letrozole induced polycystic ovary syndrome. Asian Pac J Reprod 5(2):116–122
Walters KA, Allan CM, Handelsman DJ (2012) Rodent models for human polycystic ovary syndrome. Biol Reprod 86(5):1–12
Khaled N, El-Bahy AA, Radwan R, Handoussa H, Abdel Maksoud S (2019) Ocimum kilimandscharicum L. restores ovarian functions in letrozole-induced polycystic ovary syndrome (PCOS) in rats: Comparison with metformin. Life Sci 232:116640
Ndeingang EC, Defo Deeh PB, Watcho P, Kamanyi A (2019) Phyllanthus muellerianus (Euphorbiaceae) restores ovarian functions in letrozole-induced polycystic ovarian syndrome in rats. Evid Based Complement Alternat Med 2019:2965821
Yang H, Lee SY, Lee SR, Pyun BJ, Kim HJ, Lee YH, Kwon SW, Suh DH, Lee CH, Hong EJ, Lee HW (2018) Therapeutic effect of Ecklonia cava extract in letrozole-induced polycystic ovary syndrome rats. Front Pharmacol 9:1325
Zawadski JK, Dunaif A (1992) The polycystic ovary syndrome. In: Dunaif A, Givens JR, Haseltine FP, Merriam GR (eds) The Polycystic Ovary Syndrome. Blackwell Scientific Publications, Boston, pp 377–384
Laven JS, Imani B, Eijkemans MJ, Fauser BC (2002) New approach to polycystic ovary syndrome and other forms of anovulatory infertility. Obstet Gynecol Surv 57(11):755–767
Kaiser UB (2011) Gonadotropin Hormones. In: Melmed S (ed) The Pituitary, 3rd edn. Academic Press, New York, pp 205–260
Marx TL, Mehta AE (2003) Polycystic ovary syndrome: pathogenesis and treatment over the short and long term. Cleve Clin J Med 70(1):31–45
Burghen CA, Givens JR, Kitabchi AE (1980) Correlation of hyperandrogenism with hyperinsulinemia in polycystic ovarian disease. J Clin Endocrinol Metab 50:113–116
Legro RS (2004) Polycystic ovarian syndrome. In: Leung PCK, Adashi EY (eds) The Ovary, 2nd edn. Academic Press, New York, pp 489–512
Chang RJ (2009) Polycystic ovary syndrome and hyperandrogenic states. In: Strauss JF, Barbieri RL (eds) Yen & Jaffe's Reproductive Endocrinology, 6th edn. USA, W.B, Saunders, Philadelphia, PA, pp 489–516
Zuo T, Zhu M, Xu W (2016) Roles of oxidative stress in polycystic ovary syndrome and cancers. Oxid Med Cell Longev 2016:8589318
Verit FF, Erel O (2008) Oxidative stress in nonobese women with polycystic ovary syndrome: correlations with endocrine and screening parameters. Gynecol Obstet Invest 65(4):233–239
Kucukkurt I, Ince S, Fidan AF, Ozdemir A (2008) The effects of dietary supplementation of different amount of Yucca schidigera powder (Sarsaponin 30®) on blood and tissue antioxidant defense systems and lipid peroxidation in rats. J Anim Vet Adv 7(11):1413–1417
Keles H, Ince S, Kucukkurt I, Tatli II, Akkol EK, Kahraman C, Demirel HH (2012) The effects of Feijoa sellowiana fruits on the antioxidant defense system, lipid peroxidation, and tissue morphology in rats. Pharm Biol 50(3):318–325
Kyle ME, Miccadei S, Nakae D, Farber JL (1987) Superoxide dismutase and catalase protect cultured hepatocytes from the cytotoxicity of acetaminophen. Biochem Biophys Res Commun 149(3):889–896
Matés JM, Sánchez-Jiménez F (1999) Antioxidant enzymes and their implications in pathophysiologic processes. Front Biosci 4:339–345
Hsu C, Hsieh CL, Kuo YH, Huang CJ (2011) Isolation and identification of cucurbitane-type triterpenoids with partial agonist/antagonist potential for estrogen receptors from Momordica charantia. J Agric Food Chem 59(9):4553–4561
Ruhlen RL, Sun GY, Sauter ER (2008) Black Cohosh: insights into its mechanism(s) of action. Integr Med Insights 3:21–32
Sandjo LP, Kuete V (2013) Triterpenes and steroids from the medicinal plants of Africa. In: Kuete V (ed) Medicinal plant research in Africa: Pharmacology and Chemistry. Elsevier, London, UK, pp 135–202
Funding
This study was supported by 2214/A International Research Fellowship Program, provided by "The Scientific and Technological Research Council of Turkey (TUBITAK)".
Author information
Authors and Affiliations
Contributions
MI Isolation studies and Biological Activity Studies. ZA Isolation Studies and Structure Elucidation. IAK Isolation Studies and Structure Elucidation. HT Histopathological analysis. EKA Biological Activity Studies.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Ethical approval
All applicable international, national, and/or institutional guidelines for the care and use of animals were followed. This article does not contain any studies with human participants performed by any of the authors.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ilhan, M., Ali, Z., Khan, I.A. et al. Isolation and identification of triterpenes from Anthemis austriaca Jacq. through bioactivity-guided fractionation on polycystic ovary syndrome rat model. Arch Gynecol Obstet 301, 1103–1111 (2020). https://doi.org/10.1007/s00404-020-05493-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-020-05493-7